CompletedNot Applicable

Cervical Cancer Prevention for Black Adults

United States288 participantsStarted 2023-01-01

Plain-language summary

The goal of this study is to develop and pilot test an intervention, entitled Health is Wealth: A Cervical Health Program, designed to promote screening and reduce perceived barriers to Cervical Cancer (CC) screening. Aim 1: Examine general awareness and cultural factors (fatalism, religiosity/spirituality, temporal orientation, medical mistrust, and acculturation) related to cancer control and prevention among African Americans (AA) and Sub Saharan African (SAI) Immigrants. Aim 2: Examine the socioecological barriers and facilitators to CC screening and self-sampling to inform tailoring of an evidenced based cervical health program to promote CC screening. Aim 3: Assess feasibility, acceptability, and preliminary efficacy in a pilot test of the Health is Wealth: A Cervical Health Program among 30 AA and 30 SAI women using quasi-experimental design. This study will take place in 2 phases.

Who can participate

Age range

30 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Self-identify as Black woman (African American or Sub-Saharan African Immigrant) * No pap smear within the last three years or no pap smear/HPV co-test within past five years * Able to speak and write in English * Reside in Kentucky Exclusion Criteria: * Do not self-identify as Black woman (African American or Sub-Saharan African Immigrant) * History of hysterectomy * History of cervical cancer * Being pregnant * Unable to speak and write in English * Do not reside in Kentucky

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of Participants That Completed HPV Self-sampling

Timeframe: Baseline

Change in Cervical Cancer Knowledge

Timeframe: 6 months (Baseline, immediately post-test (up to 1 week), 6 month follow up)

Change in Human Papillomavirus (HPV) Knowledge

Timeframe: 6 months (Baseline, immediately post-test (up to 1 week), 6 month follow up)

Change in Self-Efficacy in Completing Pap Test

Timeframe: 6 months (Baseline, immediately post-test (up to 1 week), 6 month follow up)

Change in Perceived Barriers to Screening

Timeframe: 6 months (Baseline, immediately post-test (up to 1 week), 6 month follow up)

Trial details

NCT IDNCT04927494

SponsorAdebola Adegboyega

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-10

Results submitted2026-05-06

View on ClinicalTrials.gov More Cervical Cancer trials

Plain-language summary

Who can participate

Age range

30 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Number of Participants That Completed HPV Self-sampling

Timeframe: Baseline

Change in Cervical Cancer Knowledge

Timeframe: 6 months (Baseline, immediately post-test (up to 1 week), 6 month follow up)

Change in Human Papillomavirus (HPV) Knowledge

Timeframe: 6 months (Baseline, immediately post-test (up to 1 week), 6 month follow up)

Change in Self-Efficacy in Completing Pap Test

Timeframe: 6 months (Baseline, immediately post-test (up to 1 week), 6 month follow up)

Change in Perceived Barriers to Screening

Timeframe: 6 months (Baseline, immediately post-test (up to 1 week), 6 month follow up)